Phibro Animal Health (PAHC) Q3 FY2024 earnings: revenue $263 million, up 7.1% on the year

Phibro Animal Health Corp. (PAHC) reported revenue of $263 million for Q3 FY2024, the quarter ended 31 March 2024, up 7.1% on the same quarter a year earlier. Net income was $8 million, down 16.3% on the year, and diluted earnings per share $0.21. The figures are the company's own, from the 10-Q it filed with the SEC on 8 May 2024.

Revenue$263 millionup 7.1%

Net income$8 milliondown 16.3%

Diluted EPS$0.21

QuarterQ3 FY2024ended 31 March 2024

The quarter, against the one before and a year earlier

Line	Q3 FY2024	Q2 FY2024	A year earlier	Change on the year
Revenue	263	250	n/a	n/a
Cost of revenue	184	171	n/a	n/a
Gross profit	79.6	78.6	n/a	n/a
Gross margin	30.2%	31.5%	n/a
Selling, general and administrative	59.7	62.9	n/a	n/a
Operating income	19.9	15.7	n/a	n/a
Operating margin	7.6%	6.3%	n/a
Interest expense	5.6	5.7	n/a	n/a
Pre-tax income	12.9	3.6	n/a	n/a
Income tax	4.5	2.3	n/a	n/a
Effective tax rate	35.0%	64.3%	n/a
Net income	8.4	1.3	n/a	n/a
Net margin	3.2%	0.5%	n/a
Diluted EPS	$0.21	$0.03	n/a	n/a

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

Line	Q3 FY2024	Q2 FY2024	A year earlier	Change on the year
Operating cash flow	11.4	31.6	n/a	n/a
Capital expenditure	9.7	11.0	n/a	n/a
Free cash flow	1.7	20.6	n/a	n/a
Free cash flow margin	0.6%	8.2%	n/a
Cash from investing	1.1	-24.9	n/a	n/a
Cash from financing	4.9	-14.7	n/a	n/a
Depreciation and amortisation	9.2	8.9	n/a	n/a
Share-based compensation	0.1	0.1	n/a	n/a
Dividends paid	4.9	4.9	n/a	n/a
Dividend per share	$0.12	$0.12	n/a	n/a
Diluted shares, weighted	41m	41m	n/a	n/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

Line	Q3 FY2024	Q2 FY2024	A year earlier	Change on the year
Shareholders' equity	270	271	n/a	n/a
Debt	321	324	n/a	n/a
Operating lease liabilities	30.1	31.2	n/a	n/a
Other liabilities	358	347	n/a	n/a
Total liabilities and equity	979	973	n/a	n/a
Fixed assets	202	201	n/a	n/a
Goodwill	54.6	54.7	n/a	n/a
Intangible assets	48.2	51.0	n/a	n/a
Investments	48.5	59.5	n/a	n/a
Cash and equivalents	50.2	33.0	n/a	n/a
Receivables	161	151	n/a	n/a
Inventory	282	287	n/a	n/a
Other assets	132	136	n/a	n/a
Total assets	979	973	n/a	n/a

Questions

What was Phibro Animal Health's revenue in Q3 FY2024?

Phibro Animal Health (PAHC) reported revenue of $263 million for Q3 FY2024, the quarter ended 31 March 2024, up 7.1% on the same quarter a year earlier.

How much did Phibro Animal Health earn in Q3 FY2024?

Net income for Q3 FY2024 was $8 million, down 16.3% on the year, and diluted earnings per share $0.21.

When did Phibro Animal Health report Q3 FY2024 results?

Phibro Animal Health filed its 10-Q for the quarter ended 31 March 2024 with the SEC on 8 May 2024.

Quarterly results, the last 12 quarters

	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026	Q4 FY2026 *
Revenue	231	250	263	273	260	309	348	379	364	374	384	397
Cost of revenue	164	171	184	186	177	207	243	269	244	241	258	262
Gross profit	67.7	78.6	79.6	87.2	83.5	102	105	110	120	133	126	134
Gross margin	29%	31%	30%	32%	32%	33%	30%	29%	33%	35%	33%	34%
SG&A	68.5	62.9	59.7	68.7	65.8	76.3	71.1	76.3	68.5	82.3	81.0	86.2
Operating income	-0.7	15.7	19.9	18.4	17.7	25.5	33.5	33.7	51.3	50.3	44.7	48.2
Operating margin	-0%	6%	8%	7%	7%	8%	10%	9%	14%	13%	12%	12%
Interest expense	5.6	5.7	5.6	6.0	8.8	9.8	9.7	9.0	12.5	12.5	10.7	10.7
Pre-tax income	-12.0	3.6	12.9	6.4	9.6	4.8	29.7	23.8	36.3	36.4	32.3	32.3
Tax rate	n/a	64%	35%	88%	27%	34%	30%	28%	27%	25%	26%	33%
Net income	-8.0	1.3	8.4	0.8	7.0	3.2	20.9	17.2	26.5	27.5	24.0	21.7
Net margin	-3%	1%	3%	0%	3%	1%	6%	5%	7%	7%	6%	5%
Diluted EPS	-$0.20	$0.03	$0.21	$0.02	$0.17	$0.08	$0.51	$0.43	$0.65	$0.67	$0.59	$0.52
Operating cash flow	16.2	31.6	11.4	28.4	12.6	3.1	43.2	21.3	9.3	19.4	16.2	24.1
Capital expenditure	7.5	11.0	9.7	13.1	9.6	7.8	7.7	13.1	13.8	11.1	15.3	18.9
Free cash flow	8.7	20.6	1.7	15.4	3.0	-4.7	35.4	8.1	-4.5	8.3	0.9	5.2
Dividends paid	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9
Filing	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 31 March 2024, filed 8 May 2024, accession 0001558370-24-007340: the filing on EDGAR. All of Phibro Animal Health Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install